IL48212A - N-((2-methyl-3-hydroxy-5-hydroxymethyl)pyridyl)-methylene-glutamic acid,its preparation and pharmaceutical compositions containing it - Google Patents

N-((2-methyl-3-hydroxy-5-hydroxymethyl)pyridyl)-methylene-glutamic acid,its preparation and pharmaceutical compositions containing it

Info

Publication number
IL48212A
IL48212A IL4821272A IL4821272A IL48212A IL 48212 A IL48212 A IL 48212A IL 4821272 A IL4821272 A IL 4821272A IL 4821272 A IL4821272 A IL 4821272A IL 48212 A IL48212 A IL 48212A
Authority
IL
Israel
Prior art keywords
pyridyl
hydroxymethyl
methylene
hydroxy
methyl
Prior art date
Application number
IL4821272A
Original Assignee
Made Labor Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Labor Sa filed Critical Made Labor Sa
Priority to IL4821272A priority Critical patent/IL48212A/en
Publication of IL48212A publication Critical patent/IL48212A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Claims (4)

1. H- 1 (2-methyl~3-hydroxy-5-hydroxymethyl) pyridyl]-methylene-glutamic acid and the tautomer thereof of the following formulae: COOH (I) COOH CH- * Φ (ID
2. / A method of preparing the compound of Claim 1, wherein alpha-ketoglutarlc acid and pyridoxamine are separately dissolved in the smallest possible quantity of an appropriate organic or inorganic solvent, the solutions thus obtained are mixed and the salt of formula (I) is precipitated by cooling or concentrating the mixture, according to the solvent used or by adding to the mixture an appropriate solvent.
3. A method according to Claim 2, wherein ethanol is used as the solvent.
4. Pharmaceutical compositions comprising, as active ingredient, the compound of formula (I) in Claim 1. For the Applicants ND:ed
IL4821272A 1972-10-25 1972-10-25 N-((2-methyl-3-hydroxy-5-hydroxymethyl)pyridyl)-methylene-glutamic acid,its preparation and pharmaceutical compositions containing it IL48212A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL4821272A IL48212A (en) 1972-10-25 1972-10-25 N-((2-methyl-3-hydroxy-5-hydroxymethyl)pyridyl)-methylene-glutamic acid,its preparation and pharmaceutical compositions containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL4821272A IL48212A (en) 1972-10-25 1972-10-25 N-((2-methyl-3-hydroxy-5-hydroxymethyl)pyridyl)-methylene-glutamic acid,its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
IL48212A true IL48212A (en) 1976-02-29

Family

ID=11048478

Family Applications (1)

Application Number Title Priority Date Filing Date
IL4821272A IL48212A (en) 1972-10-25 1972-10-25 N-((2-methyl-3-hydroxy-5-hydroxymethyl)pyridyl)-methylene-glutamic acid,its preparation and pharmaceutical compositions containing it

Country Status (1)

Country Link
IL (1) IL48212A (en)

Similar Documents

Publication Publication Date Title
GB1437136A (en) Anti-inflammatory thiazole compounds compositions and methods for using same
IL41426A (en) Process for the production of 3-amino-benzo-1,2,4-triazine di-n-oxide derivatives and pharmaceutical compositions containing such derivatives
GB1380225A (en) Biphenylyl- alkanoylaminopyridines and acid addition salts thereof
IL42513A (en) N-(1h-tetrazol-5-yl)-quinaldamide derivatives,their production and pharmaceutical compositions containing them
IE40052B1 (en) Indole derivatives
GB1456627A (en) Pyridobenzodiazepinones
ES375203A1 (en) Benzothiazepine derivatives
GB1415471A (en) Phenylethylamine derivatives
IL48212A (en) N-((2-methyl-3-hydroxy-5-hydroxymethyl)pyridyl)-methylene-glutamic acid,its preparation and pharmaceutical compositions containing it
GB1362845A (en) Benzyl alcohol derivatives
GB1451902A (en) Bromo dihydrolysergic acid
IL40661A (en) Pyridoxal alpha-ketoglutarate,its preparation and pharmaceutical compositions containing it
GB1231250A (en)
GB1529251A (en) 9,10-dihydroergopeptines
GB1412932A (en) Pharmaceutically active leurosine derivatives and preparation thereof
GB1250045A (en) A new water soluble derivative of erythromycin
IE34307B1 (en) New 1-alkyl-6-azauracil compounds and preparations which contain a 1-alkyl-6-azauracil compound as an active ingredient
GB1384523A (en) Oxime derivatives and their preparation
GB1437149A (en) Spiro-compounds and a process for their preparation
ES407866A1 (en) Preparation of n -diethylaminoethyl - 2 - methoxy- 5 - methyl sulphonylbenzamide
GB1364366A (en) Derivatives of 4-chloro-5-sulphamoyl-anthranilic acid their preparation and pahamaceutical compositions comprising them
GB1339010A (en) Tetrazolyl-anthraquinone derivatives
GB1377610A (en) 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof
GB1413407A (en) Dihydropyrido-pyrimidine derivatives their preparation and therapeutical use
IE38940L (en) Pharmaceutical compositions; salts of p-chlorohippuric acid